Ozempic Face: What It Is and What You Can Do
Share
Ozempic face is a term used to describe the facial changes that can accompany rapid weight loss on GLP-1 medications like Ozempic, Wegovy and Mounjaro. It is not a side effect of the drug itself. It is a consequence of losing a significant amount of fat quickly, including from the face.
Key Facts
- Ozempic face is caused by rapid fat and muscle loss, not by the drug itself
- It applies to all GLP-1 medications including Wegovy and Mounjaro
- 25–40% of weight lost on GLP-1 medications can be lean muscle mass, which affects the face
- Slower weight loss, adequate nutrition and resistance training can reduce the impact
What Does Ozempic Face Look Like?
The term was coined by New York dermatologist Dr Paul Jarrod Frank after treating patients experiencing visible facial changes following GLP-1 use. The changes can include:
- Sunken or hollowed cheeks
- More prominent cheekbones and temples
- Loose or sagging skin around the jaw and neck
- New or deepened wrinkles
- An overall gaunt or aged appearance
These changes are not unique to Ozempic. They can occur with any GLP-1 medication, or with any method of rapid weight loss. The drug accelerates the pace of weight loss, and it is that pace that causes the facial changes.
Why Does It Happen?
💨 Rapid fat loss
The face stores fat in two compartments. When you lose weight quickly, you lose it everywhere including here. You cannot selectively keep facial fat.
💪 Muscle loss
25–40% of weight lost on GLP-1 medications can be lean muscle mass. The face has over 20 muscles and their loss contributes directly to a deflated, sagging appearance.
📉 Skin elasticity
Skin elasticity declines naturally with age. Rapid fat loss gives skin less time to adapt, making the visual impact more pronounced in people over 40.
How Much Weight Loss Triggers It?
The degree of facial change is directly linked to the amount and speed of weight loss.
14.9%
average body weight lost by patients using semaglutide over 68 weeks in clinical trials — at this level of reduction, visible facial changes are common
People losing 10 to 15 pounds will generally see far less facial impact than those losing 50 or more. The faster the loss, the more pronounced the effect.
Is It Permanent?
Ozempic face is not necessarily permanent, but some changes are difficult to reverse without intervention. Loose skin in particular does not always return to its previous position once fat has been lost. The degree of permanence depends on age, how much weight was lost and the speed at which it was lost.
What Can You Do About It?
Slow the rate of weight loss where possible
Gradual weight loss gives skin more time to adapt. If facial changes are a concern, discussing a slower titration schedule with your prescribing clinician is worth considering.
Prioritise protein and nutrients
Muscle loss during weight loss is accelerated by inadequate protein and micronutrient intake. Ensuring sufficient vitamin D, B12 and magnesium can help support muscle maintenance during treatment. Nutrient gaps are common in GLP-1 users due to reduced food intake.
ORVO GLP-1 Support — 5 ingredients, 3 capsules daily
Vitamin D3, K2, B12, Magnesium & Ginger Root. Built for the way you're eating now.
Resistance training
Maintaining muscle through resistance exercise reduces the proportion of weight lost from lean tissue. This supports body composition and may reduce the extent of facial changes.
Cosmetic options
Some people opt for cosmetic procedures to address facial volume loss, including dermal fillers, collagen-stimulating treatments or surgical options. These decisions are personal and should involve a qualified medical practitioner.
Does It Apply to Mounjaro and Wegovy Too?
Yes. The term Ozempic face is associated with semaglutide but it applies to all GLP-1 medications. Mounjaro (tirzepatide) tends to produce greater weight loss than semaglutide in clinical comparisons, which means the facial changes can be more pronounced for some users. Wegovy face and Mounjaro face refer to the same phenomenon.
Frequently Asked Questions
- Is Ozempic face a real medical condition?
- It is not a formally recognised medical diagnosis. It is a colloquial term describing the facial changes that accompany rapid weight loss from GLP-1 medication use. The underlying mechanism, loss of facial fat and muscle, is well understood.
- Does everyone on Ozempic get Ozempic face?
- No. The likelihood and severity depend on how much weight is lost, how quickly it is lost and individual factors including age and skin elasticity. People losing smaller amounts of weight are less likely to notice significant facial changes.
- Can Ozempic face be reversed?
- Some of it can recover naturally as the body stabilises at its new weight, particularly if the weight loss was not extreme. Significant volume loss and loose skin are harder to reverse without cosmetic intervention.
- Does stopping Ozempic fix it?
- Stopping medication does not restore lost facial volume. Research shows that stopping semaglutide leads to regaining around two-thirds of lost weight within a year, but fat redistribution back to the face is unpredictable and not guaranteed.
- Is Ozempic face the same as Wegovy face or Mounjaro face?
- Yes. All three terms describe the same phenomenon. It is related to the weight loss produced by GLP-1 medications, not to any specific drug.
Sources
- Cleveland Clinic. 'Ozempic Face': What It Is and How to Avoid It. (Accessed May 2026).
- Plastic Surgery Research. 'Ozempic Face' in Plastic Surgery: A Systematic Review. PMC, 2025.
- UCLA Health. Ozempic Face and Other GLP-1 Side Effects. (Accessed May 2026).
- Drugs.com. Ozempic Face: What causes it and how to prevent it. (Accessed May 2026).